ESCRS 2023: Talking next-generation femtosecond lasers for corneal refractive surgery with Prof Rohit Shetty
The future of refractive surgery is bright, thanks to OCTs and advances in laser technology
ESCRS 2023: Dr Amir Hamid praises the wide range of technologies on view
The medical director for Optegra has piloted corneal workflows and trifocal lenses presented at the meeting
ESCRS 2023: Fritz Hengerer, MD, PhD, presents new data for cataract surgeons
The director of Frankfurt’s Bürgerhospital eye hospital shared 7 years’ data on the iStent inject®
ESCRS 2023: The three things that make this meeting a priority for Dr Sheng Lim
The glaucoma specialist spoke about his ESCRS agenda–and his calendar for 2024
ESCRS 2023: Scott D. Barnes, MD, looks to the future of user-friendly lens injectors
New cataract and refractive options from STAAR Surgical could come as early as this year
ESCRS 2023: Data-driven innovation in the glaucoma space with Keith Barton
As part of the meeting’s MIGS programme, Keith Barton, MD, FRCP, FRCS, FRCOphth, shared data from the iTrack™ Global Data Registry
ESCRS 2023: Managing directors from Heidelberg Engineering preview Orbis partnership
The diagnostic imaging experts will provide education through the Cybersight platform
ESCRS 2023: Greg Kunst looks ahead at the next 5 years of Aurion Biotech’s cell therapies
In a conversation at ESCRS, the CEO said by 2028, Aurion Biotech hopes to see global registration for its corneal endothelial disease therapies.
ESCRS 2023: Presbyopia treatment with microporation therapeutic technology by Ace Vision Group
AnnMarie Hipsley, DPT, PhD, met with Ophthalmology Times Europe to discuss Ace Vision Group's microporation therapeutic technology, used to treat presbyopia.
ESCRS 2023: Thomas Bosshard discusses Oertli's 3-platform approach
At this year's ESCRS meeting, we visited the Oertli Instruments booth, where co-CEO and co-owner Thomas Bosshard highlighted the company's 3-platform approach.
ESCRS 2023: Krysten Williams talks about bringing Heidelberg image quality into the surgical theater
At the 2023 European Society Of Cataract & Refractive Surgeons (ESCRS) meeting in Vienna, Krysten Williams, head of marketing and education at Heidelberg Engineering, spoke to our team about the newest imaging advancements in the clinic and the operating room.
ESCRS 2023: Binkhorst Medal lecture addresses the future of cataract and refractive surgery
Jorge Alio, MD, PhD, FEBOpthhal spoke with our team about his Binkhorst Medal lecture topic, the future of cataract and refractive surgery, while at the 2023 ESCRS meeting in Vienna, Austria.
Disrupting the glaucoma treatment paradigm with novel femtosecond laser from ViaLase
Shawn O'Neil of ViaLase shares updates on the company's femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT) treatment.
Trukera Medical rebranding ushers in new era of expansion into cornea market
Adam Szaronos, President and CEO of Trukera Medical, discusses the recent rebranding of TearLab as well as the launch of the ScoutPro Osmolarity System.
2-year data in contralateral eye evaluation gives edge to iStent inject over Hydrus stent
At AAO 2022, Dr Mitch Shultz provides discourse on iStent inject vs Hydrus contralateral eye evaluation data.
Younger patients often require repeat corneal crosslinking, study finds
At the 2022 American Academy of Ophthalmology meeting, Dr Philip Dockery, MPH, presents, "Effectiveness of corneal crosslinking in young patients."
Investigators report positive visual outcomes one year after monocular implantation of small aperture IOL
Dr Mark H. Blecher dives into his AAO 2022 topic: "One-Year Visual Outcomes Following Monocular Implantation with a Small Aperture IOL."
Fluid dynamics in wet macular degeneration: How fluid type affects visual acuity
At AAO 2022, Dr Justis Ehlers presented a talk entitled, "Defining the Fluid Problem in Neovascular AMD: To Dry or Not to Dry?"
Utilising AAO cornea preferred practice patterns for corneal oedema, opacifications, ectasia and bacterial keratitis
David Hutton discusses the AAO 2022 talk, "Corneal Oedema, Opacifications, Ectasia, and Bacterial Keratitis: Diagnosis and Treatment Strategies from the Preferred Practice Pattern Guidelines," with presenter Dr Francis S. Mah.
Investigating better indications and outcomes in laser refractive surgery
Prof. Martin Dirisamer speaks with Editor Caroline Richards about his ESCRS instructional course, "Mastering laser refractive surgery: Indications and outcomes."
Investigating the effects of canaloplasty on corneal epithelium
Dr David Lubeck talks with Caroline Richards of Ophthalmology Times Europe about his ESCRS presentations, touching on surgical effects on corneal epithelium and the iTrack Global Registry for glaucoma.
Avoiding errors when converting to DMEK
Prof. Martin Dirisamer discusses his instructional course on common mistakes when performing DMEK and how to avoid them at ESCRS.
EDOF lens tech is evolving to help more patients with intermediate vision
Assistant Prof. of ophthalmology Basak Bostanci discusses her ESCRS presentation, “Extended Range Of Vision In Unusual Cases” and how EDOF lens technology is evolving to include a wider pool of candidates.
Fixoflex ring: Prof. Pallikaris describes how to utilise the device during IOL implantation
Prof. Ioannis Pallikaris discusses his 2022 ESCRS presentation: "Peripheral Capsule Reconstruction And IOL Centration With The Fixoflex Ring".
The need for precision management in glaucoma moves field forward
Genotyping and artificial intelligence are together starting to predict the progression of glaucoma in individual patients, sparing them from suboptimal treatments and side effects. Recent research efforts are exploring modifiable risk factors such as caffeine consumption.
Paediatric eyes repair better with scleral buckling, adults need vitrectomy only for giant retinal tear-related detachments
At ASRS 2022, Dr Sally Ong presented a talk entitled, “Vitrectomy vs Vitrectomy With Scleral Buckling in the Treatment of Giant Retinal Tear Related Retinal Detachments: International Multicentre Study.” Here she shares the biggest takeaways.
Clinical trials in wet AMD: Impact of central subfield thickness, volatility on visual acuity
Dr Justis P. Ehlers dissects the revelations from the data in the Phase 3 Hawk clinical trial regarding the impact of central subfield thickness, volatility and the overall impact on visual acuity.
Post hoc analysis of Copernicus, Galileo trials find time since diagnosis affects BCVA outcomes in CRVO
Dr Dilsher Dhoot discusses the post hoc analysis of the Copernicus and Galileo trials, which investigated if a delay in treatment would affect visual acuity gains or change in anatomy.
Noninfectious uveitis, uveitic macular oedema: A synopsis of frontline therapies
Dr Steven Yeh provides a brief overview of available therapies for noninfectious uveitis and uveitis macular oedema.
Archway: Phase 3 end-of-trial results show Port Delivery System is noninferior to monthly ranibizumab
Dr Aleksandra Rachitskaya discussed the Phase 3 Archway end-of-trial results for the investigation of the Port Delivery System with ranibizumab in neovascular AMD.
2 Commerce Drive Cranbury, NJ 08512